Corneal Cross-Linking for Keratoconus
What is Keratoconus?
Keratoconus affects about 1 in 2,000 people, often starting in the teen years or early adulthood and progressing over time. Early diagnosis and treatment are key to managing the condition effectively and protecting your sight for the long term.
People with keratoconus may notice blurry or distorted vision that glasses do not fully correct. Other common signs include increased sensitivity to light and glare, especially at night, and frequent changes in eyeglass or contact lens prescriptions.
The exact cause of keratoconus is not fully known, but it often runs in families and has strong links to chronic eye rubbing and allergies. Certain systemic conditions, such as Down syndrome and connective tissue disorders, can also increase the risk.
As the cornea bulges into a cone shape, it bends light unevenly, leading to progressive nearsightedness and irregular astigmatism. This distortion can make daily tasks like reading, driving, or recognizing faces more difficult over time.
Keratoconus progresses through stages, starting from mild corneal thinning and distortion to advanced stages where vision severely deteriorates. Early stages can be managed with glasses or soft contacts, while more advanced stages may require specialized hard contact lenses or surgical intervention.
Diagnosis involves a comprehensive eye exam that includes corneal topography, a mapping tool that measures the cornea's curvature to detect irregularities. Your doctor will also use pachymetry to measure corneal thickness and a slit-lamp exam to observe physical changes in the eye.
Understanding Corneal Cross-Linking
Corneal cross-linking, often called CXL, uses a combination of vitamin B2 (riboflavin) eye drops and a special ultraviolet light to strengthen the cornea. This treatment has a high success rate, halting the progression of keratoconus in over 90% of treated eyes, making it one of the most important advances in protecting vision for keratoconus patients.
The procedure creates new bonds, or cross-links, between the collagen fibers within the cornea, much like reinforcing a weakened structure. After the riboflavin drops soak into the cornea, the ultraviolet light activates them to stiffen the tissue, which helps prevent further thinning and bulging.
There are two main methods. In epithelium-off CXL, the cornea's thin outer layer is removed to allow for better riboflavin absorption and is the FDA-approved standard approach. In epithelium-on CXL, this layer is left intact for faster healing, though absorption may be less effective. Your ophthalmologist will recommend the best option for you.
Ideal candidates have progressive keratoconus, meaning their vision and corneal shape are actively worsening over time. The treatment is especially effective for teens and young adults when the disease is most active. A thorough exam will determine if cross-linking is safe and appropriate for you.
Certain conditions may prevent you from being a candidate for CXL. These include having a cornea that is too thin, severe corneal scarring, an active eye infection, or certain autoimmune disorders that could impair healing.
Newer techniques include accelerated cross-linking, which shortens treatment time using higher ultraviolet intensity. Other customized protocols can be tailored to an individual's corneal characteristics to improve comfort and outcomes while maintaining safety. Our ophthalmologists stay current with the latest advances to give you the best possible results.
The Cross-Linking Procedure
The CXL procedure is a straightforward, in-clinic treatment that is minimally invasive and typically lasts between 60 to 90 minutes. You will remain awake and comfortable with the use of numbing eye drops and go home the same day.
Before your procedure, you will have a detailed eye exam to map your cornea and check its health. You may be asked to stop wearing contact lenses for a few days to a week beforehand. You will also receive instructions on your eye drop schedule and what to expect on the day of treatment.
The treatment follows a few simple steps:
- Numbing drops are first applied to your eye to ensure you are comfortable.
- For epithelium-off procedures, the thin outer corneal layer is gently removed.
- Riboflavin eye drops are then applied for about 30 minutes to saturate the corneal tissue.
- A special ultraviolet light is shined on your eye for 10 to 30 minutes to activate the riboflavin.
- A protective, soft bandage contact lens is placed on your eye to aid healing.
After the treatment, you will be given antibiotic and anti-inflammatory eye drops to prevent infection and reduce swelling. You may feel mild discomfort, light sensitivity, or tearing for a few days as your eye heals.
Recovery and Aftercare
Recovery from cross-linking is usually quick, with most patients returning to their daily routine within about a week. Following your care instructions carefully is essential for a smooth healing process and successful long-term results.
Mild pain, tearing, blurry vision, and sensitivity to bright light are normal during the first few days as the surface of your eye heals. Wearing sunglasses can help with light sensitivity, and comfort typically improves by day four or five.
For the best outcome, follow these tips:
- Use all prescribed eye drops exactly as directed.
- Avoid rubbing or touching your eye to prevent irritation and infection.
- Rest your eyes and avoid strenuous exercise or heavy lifting for the first week.
- Attend all follow-up visits so your doctor can monitor your healing.
Your vision may fluctuate and sometimes appear slightly worse during the first few weeks after treatment as the cornea heals. Gradual improvement typically occurs over the following three to six months as the corneal shape stabilizes.
Regular eye check-ups are important to track your cornea's stability for years to come. Continue to wear ultraviolet-protective sunglasses outdoors to guard against sun damage, and wait for clearance from your doctor before resuming contact lens wear.
Benefits and Risks
Cross-linking offers significant benefits by providing long-term corneal stability and reducing the likelihood of needing a transplant. While the procedure is very safe, it is important to understand the possible risks and side effects.
The main benefits of CXL include:
- Halting the progression of keratoconus.
- Maintaining stable vision for many years.
- Potentially improving vision by slightly flattening the cornea.
- Reducing or eliminating the need for a cornea transplant.
Side effects are typically temporary and manageable. These can include corneal haze, mild pain or discomfort for a few days, and fluctuating vision during healing. More serious risks, such as infection or scarring, are rare, especially when aftercare instructions are followed carefully.
Clinical studies show that corneal cross-linking successfully halts the progression of keratoconus in over 90% of patients. Most individuals maintain stable vision for ten years or more, and early intervention generally leads to the best outcomes.
You should call your doctor immediately if you experience severe pain, a sudden decrease in vision, or signs of an infection such as increased redness and discharge. Prompt attention helps address any issues quickly and effectively.
Frequently Asked Questions
Here are answers to common questions about corneal cross-linking to help you feel informed and prepared for your treatment and recovery.
No, cross-linking does not cure keratoconus, but it effectively stops the condition from getting worse by strengthening the cornea. For most patients, this means their vision will remain stable without further progression of the disease.
Results are intended to be permanent and can last for many years. Studies show stability for up to 10 years or more in the vast majority of patients. Adhering to long-term care, such as avoiding eye rubbing, helps maintain the results.
Most patients feel little to no pain during the procedure itself due to powerful numbing drops. Mild to moderate discomfort, similar to a corneal abrasion, may occur for a few days afterward but is usually well-managed with prescribed eye drops and pain relievers.
Yes, most patients will still need glasses or specialized contact lenses to achieve their best vision. Cross-linking stabilizes the cornea but does not fully correct existing refractive errors. Your prescription may change as your eye heals.
Most patients take about one week off from work or school to allow the surface of the eye to heal. You can typically resume light activities within a few days, but visually demanding tasks may feel uncomfortable until healing is more advanced.
Many insurance plans now cover FDA-approved corneal cross-linking for the treatment of progressive keratoconus. However, coverage varies by provider. Our team can help you verify your benefits and discuss any out-of-pocket costs.
If your cornea is thinner than the standard safety limit, your surgeon may be able to use a customized protocol. Options to safely perform the procedure include:
- Using special hypoosmolar riboflavin drops to temporarily swell the cornea.
- Applying a protective, filter-like contact lens during the procedure.
- Using customized ultraviolet light dosing tailored to the corneal thickness.
While uncommon, a repeat treatment may be considered if there is documented evidence of disease progression after the initial procedure has fully healed. Your surgeon will re-evaluate your corneal thickness and overall eye health before making a recommendation.
Yes, cross-linking is a proven and effective treatment for post-LASIK ectasia, a rare complication of laser vision correction where the cornea destabilizes. The procedure works to restore corneal stability and prevent further vision loss.
Mild pain, light sensitivity, tearing, and blurry vision are all normal during the first week of healing. Red flags that require an immediate call to your doctor include severe, worsening pain, a sudden loss of vision, or thick, colored discharge from the eye.
Taking Care of Your Eyes
Managing keratoconus with corneal cross-linking is an effective way to protect your sight and maintain your quality of life. If you have concerns about keratoconus or want to learn whether cross-linking is right for you, ReFocus Eye Health Hatboro is here to help. Our ophthalmologists provide personalized, expert care for patients throughout Hatboro, Warminster, Southampton, Abington, and the surrounding communities. Schedule a comprehensive eye exam today to take the first step toward stable, healthy vision for years to come.
I went in for a scratch on my cornea. Xavier was excellent, and the doctor was very good too! Excellent care all around. The girl at the front desk was great as well. Highly recommend this facility!
Barry Rosenfeld
Patient 40+ years. Friendly, professional staff. Dr. Clark expertly handled my complex cataract surgery involving my cornea (Fuch’s Dystrophy), giving clear support throughout. Highly recommend!
Ellen Segal-Smith
Excellent visit! Very satisfied with Dr. Amin’s professionalism, thoroughness, and care. She made me feel comfortable and confident in my treatment. Highly recommend!
William Lucas
Had an amazing cataract surgery with femto laser & symphony lens by Dr. Clark. Superwoman now! He’s rare, spends time, builds trust. Life quality improved greatly. Highly recommend!
Helene Senior
Dr. Amin is highly qualified, thorough, and explains my condition clearly. Busy practice with great doctors; worth the wait. I won’t go anywhere else but here now!
Scott Arnold
Contact Us
Tuesday: 8AM-4PM
Wednesday: 8AM-4PM
Thursday: 8AM-4PM
Friday: 8AM-4PM
Saturday: Closed
Sunday: Closed